Caroline Cecil Kaufman | Clinical Psychology | Best Researcher Award

Dr. Caroline Cecil Kaufman | Clinical Psychology | Best Researcher Award

Dr. Caroline C. Kaufman is an Assistant Psychologist at McLean Hospital and Instructor in Psychiatry at Harvard Medical School. She earned her Ph.D. in Clinical Psychology from the University of Memphis, with a specialization in the psychology of religion and spirituality. Her work lies at the intersection of spirituality, trauma, and mental health, particularly among underserved and marginalized populations. Dr. Kaufman has developed spiritually integrated psychotherapeutic interventions and conducted groundbreaking research on antisemitism, PTSD, and alcohol misuse. She has trained at leading institutions, including Yale School of Medicine, and currently leads multiple funded projects aimed at adapting clinical care to spiritual and religious diversity. Dr. Kaufman is widely recognized for her academic contributions and advocacy for inclusive behavioral health. Her professional mission centers on empowering vulnerable communities through evidence-based, spiritually inclusive mental health research and care. She is also a frequent speaker and active contributor to national and international psychology organizations.

Profile

🎓 Education

Dr. Kaufman’s clinical and academic experience spans leading institutions in psychology and psychiatry. She currently serves as Assistant Psychologist at McLean Hospital and Instructor at Harvard Medical School. From 2021 to 2023, she was a Postdoctoral Fellow in the Spirituality and Mental Health Program at McLean. Her internship was at Yale-New Haven Hospital, where she worked in child and adolescent intensive outpatient care and the Yale Gender Program. She has held clinical roles across diverse settings, including Le Bonheur Children’s Hospital, Daybreak Treatment Center, and Head Start programs. She also held supervisory roles, including at Yale and the University of Memphis. Dr. Kaufman has been actively engaged in research, professional service, and teaching throughout her career. Her expertise lies in integrating spirituality and trauma-focused therapies, and she serves as Principal Investigator on several funded research projects. She also advises diversity and inclusion initiatives across clinical psychology organizations.

🧪 Experience

Dr. Kaufman has received numerous accolades for her academic and clinical contributions. In 2024, she was awarded the Eleanor and Miles Shore Fellowship by McLean Hospital and Harvard Medical School. She is a 2022 Livingston Fellow at Harvard Medical School and was selected for the prestigious Yale Program for Medicine, Spirituality, & Religion Fellowship in 2020. That same year, she received the Jewish Community Hero Award. Other honors include the International Research Network’s Early Career Researcher Award (2022), the Graduate Student Talk Award from the Tennessee Psychological Association (2018), and the Sigma Xi Undergraduate Research Award from Williams College (2015). Dr. Kaufman has been consistently recognized for her innovative research in spirituality and mental health, her leadership in DEI initiatives, and her commitment to advancing culturally sensitive clinical care. She also received multiple travel and presentation awards from the APA and other scholarly organizations throughout her academic training.

🏅 Awards and Honors

Dr. Kaufman has received numerous accolades for her academic and clinical contributions. In 2024, she was awarded the Eleanor and Miles Shore Fellowship by McLean Hospital and Harvard Medical School. She is a 2022 Livingston Fellow at Harvard Medical School and was selected for the prestigious Yale Program for Medicine, Spirituality, & Religion Fellowship in 2020. That same year, she received the Jewish Community Hero Award. Other honors include the International Research Network’s Early Career Researcher Award (2022), the Graduate Student Talk Award from the Tennessee Psychological Association (2018), and the Sigma Xi Undergraduate Research Award from Williams College (2015). Dr. Kaufman has been consistently recognized for her innovative research in spirituality and mental health, her leadership in DEI initiatives, and her commitment to advancing culturally sensitive clinical care. She also received multiple travel and presentation awards from the APA and other scholarly organizations throughout her academic training.

🔬 Research Focus

Dr. Kaufman’s research focuses on the integration of spirituality, religiosity, and psychological science, particularly in the treatment of trauma, PTSD, and alcohol misuse. Her scholarship explores how spiritual identity and belief systems influence mental health outcomes, with a strong emphasis on marginalized and high-risk populations such as first responders and Jewish communities facing antisemitism. She leads several research projects, funded by organizations such as the John Templeton Foundation and Harvard Medical School, examining spiritually integrated psychotherapy, resilience among trauma survivors, and inclusion of religious diversity in behavioral health. She also investigates antisemitic prejudice and its psychological effects. Through both qualitative and quantitative methodologies, her work advances clinical science by developing culturally and spiritually sensitive interventions. Dr. Kaufman’s interdisciplinary research informs clinical practices and policy frameworks to promote inclusive, evidence-based care. She also collaborates across academic and community settings to ensure her research has practical, population-level impact.

Conclusion

Publications

  • Mental Health Clinical Pastoral Education—A Specialized CPE Program

    Religions
    2025-07 | Journal article | Author
    CONTRIBUTORS: Angelika A. Zollfrank; Caroline Cecil Kaufman; David H. Rosmarin
  • The scale matters: assessing body size with figure rating scales in a diverse sample of young adults

    Eating and Weight Disorders
    2022 | Journal article
  • Integrating Spirituality in Group Psychotherapy with First Responders: Addressing Trauma and Substance Misuse

    Religions
    2022-11 | Journal article | Author
    CONTRIBUTORS: Caroline Cecil Kaufman; David Hillel Rosmarin; Hilary Connery
  • Parenting in matched pairs of women of color experiencing intimate partner violence and living with and without HIV

    Journal of Traumatic Stress
    2021 | Journal article
    EID: 2-s2.0-85116930252
    Part of ISSN: 15736598 08949867
    CONTRIBUTORS: Thurston, I.B.; Howell, K.H.; Kaufman, C.C.; Mandell, J.E.; Decker, K.M.

Korchia Theo | Psychiatry | Best Researcher Award

Dr. Korchia Theo | Psychiatry | Best Researcher Award

Dr. Théo Korchia 🇫🇷 is a French psychiatrist specializing in early-onset schizophrenia 🧩, with a passion for innovation in mental health care 💡. Based at Aix-Marseille University and APHM 🏥, he completed a research fellowship at McGill University in Montreal 🇨🇦. His groundbreaking work emphasizes personalizing antipsychotic treatment using pharmacogenetics 🧬, improving patient adherence and quality of life ❤️. His notable contributions include addressing sexual dysfunction in schizophrenia treatment 💔, a topic often neglected. He published a major meta-analysis in JAMA Psychiatry 📘, shedding light on its prevalence. Winner of the Schizophrenia International Research Society award 🏆, Dr. Korchia advocates for a psychiatry that is humane, patient-centered, and scientifically rigorous 🔬. His work not only enhances clinical outcomes but also builds stronger therapeutic alliances through trust and transparency 🤝. Driven by compassion and innovation, he envisions a future where mental health care is personalized, inclusive, and profoundly impactful 🌍.

Profile

Education 🎓

Théo Korchia began his medical education in France 🎓, obtaining his degree in psychiatry with a focus on early-onset psychotic disorders 🧠. Supported by Aix-Marseille University and APHM 🏥, his academic journey was enriched by international exposure at McGill University 🇨🇦, where he deepened his expertise in psychiatric research and pharmacogenetics 🧬. His commitment to academic excellence led to extensive training in clinical practice, psychopharmacology, and patient-centered care 🩺. Throughout his studies, he explored the intersection of pharmacology, genetics, and psychiatry, aiming to personalize schizophrenia treatment for better efficacy and fewer side effects 🧪. His education was marked by a strong emphasis on translational research, ethics, and therapeutic alliance 🤝. Dr. Korchia continues to be involved in academic teaching and mentoring, sharing his knowledge with students and young professionals 📚. His education forms the bedrock of his mission: to evolve psychiatric care into a more compassionate, evidence-based, and individualized discipline 🌟.

Experience 👨‍🏫

Dr. Korchia’s clinical journey began in France 🇫🇷 at APHM and Aix-Marseille University 🏥, where he treated patients with early-onset schizophrenia and related psychotic disorders 🧠. His international experience includes a transformative year of research at McGill University 🇨🇦, focusing on pharmacogenetics and treatment personalization 🧬. In both hospital and research settings, he has contributed to improving psychiatric care through innovative approaches, especially regarding the management of antipsychotic side effects 🩻. With a hands-on approach, he integrates patient voices in treatment plans 🗣️, fostering therapeutic alliance and adherence 🤝. He has collaborated with multidisciplinary teams, presented findings at international conferences 🌐, and published in high-impact journals like JAMA Psychiatry 📘. Passionate about breaking stigmas, Dr. Korchia also advocates for the recognition of sexual dysfunction in psychiatric care 💔. His experience bridges cutting-edge science and compassionate care, making him a leading voice in progressive psychiatry 💡.

Awards & Recognitions 🏅

Dr. Théo Korchia was honored by the Schizophrenia International Research Society 🏆 for his pioneering research in early-onset schizophrenia treatment 🧠. He was supported by Aix-Marseille University and the Assistance Publique des Hôpitaux de Marseille 🎓🏥, which facilitated his international research fellowship at McGill University 🇨🇦. His impactful publication in JAMA Psychiatry 📘—a meta-analysis involving 21,000+ patients—highlighted sexual dysfunction prevalence in schizophrenia, earning him global recognition 🌍. His work addressing often-ignored dimensions of psychiatric care, such as sexual health 💔, has been lauded for its clinical relevance and humanistic perspective. Known for combining scientific rigor 🔬 with empathy ❤️, he is frequently invited to share insights at conferences and symposiums worldwide 🎤. These accolades reflect not only academic excellence but also his commitment to enhancing patient-centered care 🧩. Dr. Korchia’s recognition symbolizes a growing awareness of the holistic needs of individuals with mental illness 🌟.

Research Interests 🔬

Dr. Korchia’s research centers on early-onset schizophrenia 🧠, with a sharp focus on pharmacogenetics 🧬 to personalize antipsychotic treatments and minimize side effects. He addresses the often-overlooked issue of sexual dysfunction 💔 in schizophrenia, a side effect that significantly impacts quality of life and treatment adherence 📉. His landmark meta-analysis in JAMA Psychiatry 📘 quantified this burden, influencing clinical guidelines and public discourse. He explores how integrating patient perspectives and improving therapeutic alliances 🤝 can enhance outcomes. His work bridges biological psychiatry and patient-centered care 🩺, emphasizing that innovation is not just drug development, but rethinking care models to reflect human experience 🧠❤️. He champions the inclusion of sexual health in risk-benefit analysis of psychiatric medications 💡. Ultimately, Dr. Korchia’s goal is to evolve psychiatry into a more humane, personalized, and effective field—where each treatment plan respects the unique biology and lived experience of the individual 🌍.

Publications 
  • Impact of perceived side-effects of psychotropic treatments on quality of life in patients with severe mental illness

    Dialogues in Clinical Neuroscience
    2025-12-31 | Journal article
    CONTRIBUTORS: Théo Korchia; Mélanie Faugère; Vincent Achour; Eloïse Maakaron; Christelle Andrieu-Haller; Guillaume Fond; Christophe Lançon
  • Lifetime sexual violence experienced by women asylum seekers and refugees hosted in high-income countries: Literature review and meta-analysis

    Journal of Forensic and Legal Medicine
    2024-01 | Journal article
    CONTRIBUTORS: Laura Cayreyre; Théo Korchia; Anderson Loundou; Maeva Jego; Didier Théry; Julie Berbis; Gaëtan Gentile; Pascal Auquier; Jérémy Khouani
  • Sexual Dysfunction in Schizophrenia

    JAMA Psychiatry
    2023-11-01 | Journal article
    Part ofISSN: 2168-622X
    CONTRIBUTORS: Théo Korchia; Vincent Achour; Mélanie Faugere; Ali Albeash; Dong Keon Yon; Laurent Boyer; Guillaume Fond
  • Utilizing pharmacogenetics when treating first episode psychosis

    Journal of Psychiatry and Neuroscience
    2023-01-03 | Journal article
    Part of ISSN: 1180-4882
    CONTRIBUTORS: Theo Korchia; Ridha Joober; Raphaelle Richieri; Priyadharshini Sabesan; Lena Palaniyappan